Survival benefit of local consolidative therapy for patients with single-organ metastatic pancreatic cancer: a propensity score-matched cross-sectional study based on 17 registries

Survival benefit of local consolidative therapy for patients with single-organ metastatic pancreatic cancer: a propensity score-matched cross-sectional study based on 17 registries

BackgroundThe continuous exploration of oligometastatic disease has led to the remarkable achievements of local consolidative therapy (LCT) and favorable outcomes for this disease. Thus, this study investigated the potential benefits of LCT in patients with single-organ metastatic pancreatic ductal...

Full description

Bibliographic Details
Main Authors: Xiaolong Hu, Dan Hu, Bowen Fu, Hongqi Li, Gang Ren, Hefei Liu, Jiazhao Song, Xiaoli Kang, Xuan Wang, Haifeng Pang, Chen Liu, Jianchun Zhang, Yingjie Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Endocrinology
Subjects:
oligometastatic
local consolidative therapy
single-organ metastatic pancreatic cancer
radiotherapy
surgery
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1225979/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2023.1225979/full

Similar Items